These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1270270)

  • 1. A model for estimating population exposures due to the operation of high-energy accelerators at the Lawrence Berkeley Laboratory.
    Stephens LD; Thomas RH; Thomas SB
    Health Phys; 1976 May; 30(5):404-7. PubMed ID: 1270270
    [No Abstract]   [Full Text] [Related]  

  • 2. Operational radiation protection in high-energy physics accelerators: implementation of ALARA in design and operation of accelerators.
    Fassò A; Rokni S
    Radiat Prot Dosimetry; 2009 Nov; 137(1-2):94-9. PubMed ID: 19783841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing the requirement to reduce radiation exposure to "as low as practicable" at the Lawrence Berkeley Laboratory.
    Thomas RH
    Health Phys; 1976 Mar; 30(3):271-9. PubMed ID: 815206
    [No Abstract]   [Full Text] [Related]  

  • 4. Population exposure from high-energy accelerators.
    Stephens LD; Thomas RH; Thomas SB
    Health Phys; 1975 Dec; 29(6):853-60. PubMed ID: 1201952
    [No Abstract]   [Full Text] [Related]  

  • 5. [The status of the upper respiratory tract and function of the olfactory analyzer in personnel working with nuclear accelerators].
    Ostapkovich VE
    Klin Med (Mosk); 1969 Feb; 47(2):112-4. PubMed ID: 5379247
    [No Abstract]   [Full Text] [Related]  

  • 6. An approximate relation for the prediction of the dose rate from radioactivity induced in high energy particle accelerators.
    Sullivan AH
    Health Phys; 1972 Aug; 23(2):253-5. PubMed ID: 4644596
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physical viewpoints on radiation protection with respect to the use of particle accelerators i research and technology].
    Wideröe R
    Strahlenschutz Forsch Prax; 1968; 8():99-122. PubMed ID: 4999842
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heavy particle radiotherapy at the University of California Lawrence Berkeley Laboratory. Clinical studies by the Northern California Oncology Group].
    Castro JR; Gademann G; Collier JM; Linstad D; Pitluck S; Woodruff K; Gauger G; Char D; Gutin P; Phillips TL
    Strahlenther Onkol; 1987 Jan; 163(1):9-16. PubMed ID: 3101214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical viewpoints on radiation protection with respect to therapy with particle accelerators].
    Schumacher W
    Strahlenschutz Forsch Prax; 1968; 8():37-48. PubMed ID: 4999839
    [No Abstract]   [Full Text] [Related]  

  • 10. A nuclear fragmentation energy deposition model.
    Ngo DM; Wilson JW; Fogarty TN; Buck WW
    IEEE Trans Nucl Sci; 1991 Feb; 38(1):1-8. PubMed ID: 11538186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical radiation physics. ORNL-4168.
    Neufeld J; Ritchie RH; Anderson VE; Ashley JC; Crowell J; Feezell M; Fox K; Garrett WR; Hamm RN; Johnson L
    ORNL; 1967 Jul; ():121-34. PubMed ID: 5597971
    [No Abstract]   [Full Text] [Related]  

  • 12. Environmental levels of radioactivity at Atomic Energy Commission installations. 1. Lawrence Berkeley Laboratory, January-December 1971. 2. Savannah River Plant, January-December 1971.
    Radiat Data Rep; 1974 Feb; 15(2):89-102. PubMed ID: 4406009
    [No Abstract]   [Full Text] [Related]  

  • 13. Science and politics: free speech controversy at lawrence laboratory.
    Boffey PM
    Science; 1970 Aug; 169(3947):743-5. PubMed ID: 17820300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent measurements for hadrontherapy and space radiation: nuclear physics.
    Miller J
    Phys Med; 2001; 17 Suppl 1():45-9. PubMed ID: 11770536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Actual state survey of the use of radioisotope instruments in Japan (author's transl)].
    Suzuki H; Kuze I; Mogi A; Kataoka T; Tatsuno T; Sawa H; Fukushima T
    Radioisotopes; 1981 Mar; 30(3):186-93. PubMed ID: 7291624
    [No Abstract]   [Full Text] [Related]  

  • 16. Current considerations in heavy charged-particle radiotherapy: a clinical research trial of the University of California Lawrence Berkeley Laboratory, Northern California Oncology Group, and Radiation Therapy Oncology Group.
    Castro JR; Chen GT; Blakely EA
    Radiat Res Suppl; 1985; 8():S263-71. PubMed ID: 3937173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new model for calculation of high-energy nucleon penetration through matter.
    Turner JE; Wright HA; Grossen JH
    Health Phys; 1970 Jan; 18(1):80-2. PubMed ID: 5414974
    [No Abstract]   [Full Text] [Related]  

  • 18. Monte Carlo calculations of the dose induced by charged pions and comparison with experiment.
    Armstrong TW; Chandler KC
    Radiat Res; 1972 Nov; 52(2):247-62. PubMed ID: 4643157
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radiation protection measurements on the Siemens 42 MeV Betatron].
    Rassow J
    Strahlenschutz Forsch Prax; 1968; 8():87-97. PubMed ID: 4999841
    [No Abstract]   [Full Text] [Related]  

  • 20. Galactic HZE propagation through the Earth's atmosphere.
    Wilson JW; Townsend LW; Badavi FF
    Radiat Res; 1987; 109():173-83. PubMed ID: 11538856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.